Ctt Pharmaceutical Holdings, INC. (CTTH) — SEC Filings
Latest SEC filings for Ctt Pharmaceutical Holdings, INC.. Recent S-1 filing on Dec 30, 2025. AI-decoded analysis of earnings, risk factors, and insider tra
View Ctt Pharmaceutical Holdings, INC. on SEC EDGAR
Overview
Ctt Pharmaceutical Holdings, INC. (CTTH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a S-1 filed on Dec 30, 2025: CTT Pharmaceutical Holdings, Inc. (CTTH) filed an S-1 on December 30, 2025, to register up to 6,250,000 shares of common stock for resale by RH2 Equity Partners, a selling stockholder. The company specializes in fast-dissolving drug delivery systems, including advanced oral delivery thin dissolvable
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 bearish. The dominant filing sentiment for Ctt Pharmaceutical Holdings, INC. is bearish.
Filing Type Overview
Ctt Pharmaceutical Holdings, INC. (CTTH) has filed 1 S-1 with the SEC between Dec 2025.
Recent Filings (1)
-
CTTH Files S-1 for RH2 Resale, Seeks $3M to Fund Drug Delivery Tech
— S-1 · Dec 30, 2025 Risk: high
CTT Pharmaceutical Holdings, Inc. (CTTH) filed an S-1 on December 30, 2025, to register up to 6,250,000 shares of common stock for resale by RH2 Equity Partners
Risk Profile
Risk Assessment: Of CTTH's 1 recent filings, 1 were flagged as high-risk, 0 as medium-risk, and 0 as low-risk. The overall risk profile suggests elevated risk that warrants close monitoring.
Key Executives
- Ryan Khouri
- Frank J. Hariton, Esq.
Industry Context
CTT Pharma operates in the pharmaceutical and nutraceutical delivery systems market, focusing on innovative dissolvable film technology. This sector is characterized by intense competition from established pharmaceutical companies and emerging biotech firms. Key trends include the demand for patient-friendly drug delivery methods, the growth of the nutraceutical market, and the increasing importance of intellectual property and regulatory compliance.
Top Tags
Pharmaceuticals (1) · Drug Delivery (1) · S-1 Filing (1) · Equity Line of Credit (1) · Dilution Risk (1) · Going Concern (1) · Development Stage Company (1)
Key Numbers
- Shares of Common Stock: 6,250,000 — Offered for resale by Selling Stockholder
- Potential Proceeds: $3.0M — From Equity Line of Credit (ELOC) to the company
- Planned Equipment Investment: $0.5M — Minimum spend to bring manufacturing in-house
- Net Loss: ($250,229) — For fiscal year ended December 31, 2024
- Common Stock Outstanding: 58,712,232 — Prior to this offering
- Share Price: $0.0461 — Closing price on OTCQB on December 26, 2025
Frequently Asked Questions
What are the latest SEC filings for Ctt Pharmaceutical Holdings, INC. (CTTH)?
Ctt Pharmaceutical Holdings, INC. has 1 recent SEC filings from Dec 2025, including 1 S-1. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CTTH filings?
Across 1 filings, the sentiment breakdown is: 1 bearish. The dominant sentiment is bearish.
Where can I find Ctt Pharmaceutical Holdings, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ctt Pharmaceutical Holdings, INC. (CTTH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ctt Pharmaceutical Holdings, INC.?
Financial highlights for Ctt Pharmaceutical Holdings, INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for CTTH?
The investment thesis for CTTH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Ctt Pharmaceutical Holdings, INC.?
Key executives identified across Ctt Pharmaceutical Holdings, INC.'s filings include Ryan Khouri, Frank J. Hariton, Esq..
What are the main risk factors for Ctt Pharmaceutical Holdings, INC. stock?
Of CTTH's 1 assessed filings, 1 were flagged high-risk, 0 medium-risk, and 0 low-risk.
What are recent predictions and forward guidance from Ctt Pharmaceutical Holdings, INC.?
Forward guidance and predictions for Ctt Pharmaceutical Holdings, INC. are extracted from SEC filings as they are enriched.